About ORGANOBALANCE
ORGANOBALANCE is a Healthcare company based in Berlin (Germany) founded in 2001 by Christine Lang, and was acquired by Novozymes in September 2016. It operates as an industrial enzymes and microorganisms are developed and produced. The company has 6,781 employees. Its chief executive is Christine Lang. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is NOVOZYMES A/S.
Company details
ORGANOBALANCE was founded in 2001 in Berlin, Germany, within the biotechnology sector. Industrial enzymes and microorganisms are developed and produced through fermentation processes involving genetically modifiable strains. Operations include the creation of proteins and biopharmaceutical ingredients to support various industrial applications. The company maintains its headquarters in Germany, focusing on enzyme production for specialized uses.
- Headquarters Berlin, Germany
- Employees 6,781
- Founders Christine Lang
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website organobalance.de
- Acquired by Novozymes (Sep 2016)
- Legal Name Novozymes A/S
Investors in ORGANOBALANCE
ORGANOBALANCE has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novozymes.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biosolutions and enzymes are developed for biotechnology applications across industries. | 2000 | novozymes.com | Bagsvaerd, Denmark |
Investor details for ORGANOBALANCE
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ORGANOBALANCE
1 people are tracked at ORGANOBALANCE (1 in leadership); the tracked headcount is 6,781.
| Name | Role | Group |
|---|---|---|
Christine Lang | Co-Founder & CEO | Leadership |
Complete people profiles for ORGANOBALANCE
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ORGANOBALANCE
2 dated milestones of ORGANOBALANCE across 15 years, from founding to its latest funding, stage changes and deals.
- Founded ORGANOBALANCE is founded.
- Exit Acquired by Novozymes.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as ORGANOBALANCE (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ORGANOBALANCE
ORGANOBALANCE was founded in 2001.
ORGANOBALANCE is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Christine Lang is the current CEO of ORGANOBALANCE. They have also founded this company.
ORGANOBALANCE has 6,781 employees.
ORGANOBALANCE was founded in 2001 in Berlin, Germany, within the biotechnology sector. Industrial enzymes and microorganisms are developed and produced through fermentation processes involving genetically modifiable strains. Operations include the creation of proteins and biopharmaceutical ingredients to support various industrial applications. The company maintains its headquarters in Germany, focusing on enzyme production for specialized uses.
ORGANOBALANCE has 1 investor. Key investors include Novozymes.
ORGANOBALANCE operates through Novozymes A/S.
Yes. ORGANOBALANCE was acquired by Novozymes in September 2016.